Overview

Measuring the Neuroimmune Response to Alcohol

Status:
Enrolling by invitation
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This study uses positron emission tomography imaging of the 18-kDa translocator protein to measure the brain's immune response to alcohol.
Phase:
Early Phase 1
Details
Lead Sponsor:
Yale University
Treatments:
Ethanol